Michel Vulfovich

1.9k total citations · 1 hit paper
9 papers, 145 citations indexed

About

Michel Vulfovich is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Michel Vulfovich has authored 9 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Michel Vulfovich's work include Pancreatic and Hepatic Oncology Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Michel Vulfovich is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Michel Vulfovich collaborates with scholars based in United States. Michel Vulfovich's co-authors include Caio Rocha-Lima, Teresita Pérez González, Nabil F. Saba, Atif Hussein, Luis E. Raez, Muaiad Kittaneh, Pasquale Benedetto, Jessica MacIntyre, Afonso Ribeiro and Alberto J. Montero and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Neuro-Oncology.

In The Last Decade

Michel Vulfovich

9 papers receiving 140 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Folate Receptor Alpha—A Novel Approach to Cancer Therapy

2024 52 citations Teresita Pérez González, Michel Vulfovich et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Vulfovich United States	6	59	54	23	19	18	9	145
Navreet Dhindsa United States	5	73 1.2×	38 0.7×	36 1.6×	14 0.7×	18 1.0×	9	114
Xuan Wu China	6	54 0.9×	120 2.2×	31 1.3×	30 1.6×	13 0.7×	13	187
Kate Connor Ireland	7	22 0.4×	60 1.1×	35 1.5×	13 0.7×	23 1.3×	16	125
Susan Wróblewski United States	8	54 0.9×	82 1.5×	10 0.4×	13 0.7×	21 1.2×	19	150
Ziqi Jia China	10	88 1.5×	87 1.6×	60 2.6×	25 1.3×	37 2.1×	36	230
Fumito Tamura Japan	7	76 1.3×	134 2.5×	16 0.7×	19 1.0×	22 1.2×	27	253
Marina Natoli Switzerland	5	64 1.1×	85 1.6×	20 0.9×	14 0.7×	9 0.5×	7	172
Ryan M. Winters United States	5	94 1.6×	50 0.9×	44 1.9×	9 0.5×	62 3.4×	5	162
Heidie Frisco Cabanos Japan	3	64 1.1×	89 1.6×	46 2.0×	6 0.3×	13 0.7×	4	161
Assma Ben Aïssa Switzerland	4	26 0.4×	29 0.5×	29 1.3×	6 0.3×	14 0.8×	12	92

Countries citing papers authored by Michel Vulfovich

Since Specialization

Citations

This map shows the geographic impact of Michel Vulfovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Vulfovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Vulfovich more than expected).

Fields of papers citing papers by Michel Vulfovich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Vulfovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Vulfovich. The network helps show where Michel Vulfovich may publish in the future.

Co-authorship network of co-authors of Michel Vulfovich

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Vulfovich. A scholar is included among the top collaborators of Michel Vulfovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Vulfovich. Michel Vulfovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

González, Teresita Pérez, et al.. (2025). Bispecific Antibodies in Solid Tumors: Advances and Challenges. International Journal of Molecular Sciences. 26(12). 5838–5838. 6 indexed citations

2.

Vulfovich, Michel, et al.. (2024). Claudins in Cancer: A Current and Future Therapeutic Target. International Journal of Molecular Sciences. 25(9). 4634–4634. 19 indexed citations

3.

González, Teresita Pérez, et al.. (2024). Folate Receptor Alpha—A Novel Approach to Cancer Therapy. International Journal of Molecular Sciences. 25(2). 1046–1046. 52 indexed citations breakdown →

4.

Raez, Luis E., Arjun Khunger, Kelly King, et al.. (2020). NCOG-34. AN ASSESSMENT OF OVERALL SURVIVAL AND PALLIATIVE CARE USE AMONG PATIENTS WITH GLIOSARCOMA DIAGNOSED OVER A TWELVE-YEAR SPAN. Neuro-Oncology. 22(Supplement_2). ii136–ii136. 1 indexed citations

5.

Kittaneh, Muaiad, Alberto J. Montero, Víctor Amado, et al.. (2011). Phase I trial of weekly and every 3 weeks ixabepilone (Ix) and sunitinib (S) in advanced solid tumors (STs).. Journal of Clinical Oncology. 29(15_suppl). 3081–3081. 1 indexed citations

6.

Vulfovich, Michel & Caio Rocha-Lima. (2008). Novel advances in pancreatic cancer treatment. Expert Review of Anticancer Therapy. 8(6). 993–1002. 46 indexed citations

7.

Merchan, Jaime R., Jessica MacIntyre, Kristen K. Ciombor, et al.. (2008). A pilot study of gemcitabine (g), oxaliplatin (o), cetuximab (c) for locally advanced or metastatic pancreatic cancer. Journal of Clinical Oncology. 26(15_suppl). 15510–15510. 3 indexed citations

8.

Vulfovich, Michel & Nabil F. Saba. (2005). Technology evaluation: mapatumumab, Human Genome Sciences/GlaxoSmithKline/Takeda.. PubMed. 7(5). 502–10. 10 indexed citations

9.

Vulfovich, Michel & Nabil F. Saba. (2004). Molecular biological design of novel antineoplastic therapies. Expert Opinion on Investigational Drugs. 13(6). 577–607. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact